Application of LC-MS/MS Method for Evaluating Rosuvastatin Affinity with OATP1B1 and OATP2B1 in vitro

被引:1
|
作者
Zhang, Zhi-Yu [1 ,2 ]
Li, Quan-Sheng [2 ]
Si, Duan-Yun [2 ]
Yi, Xiu-Lin [2 ]
Liu, Chang-Xiao [2 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China
[2] Tianjin Inst Pharmaceut Res, State Key Lab Drug Delivery Technol & Pharmacokin, Tianjin 300193, Peoples R China
关键词
LC/MS/MS; Transporter; Rosuvastatin; OATP1B1; OATP2B1; HUMAN PLASMA; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; HEPATIC-UPTAKE; TRANSPORTERS; QUANTIFICATION; DRUG; PHARMACOKINETICS; ACID; HPLC;
D O I
10.14233/ajchem.2014.15376
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug-drug interaction is one of the Most important preclinical investigation directions, It may have serious impact on drug absorption, distribution and elimination through Membrane transporters, Liquid chromatography/Tandem Mass spectrometry (LC/MS/MS) Could be used to investigate drug drug interaction in vitro. A sensitive LC/MS/MS method was established for quantification of rosuvastatin in HEK293 and S2 cell lysates. Internal standard (IS) was indapamide. Detection mode was positive eleetrospray ionization. The lower limit of quantification (LLOQ) was 0.05 ng/mL. The affinity of rosuvastatin with organic anion transporting polypeptides 1B1 and 2B1 (OATP1B1 and OATP2B1) was investigated through uptake experiment, All cell samples were precipitated with methanol. Analytes were separated by reversed-phase chromatography and analyze by Tandem mass spectrometry using m/z 482.2/258.1 for rosuvastatin and m/z 366.1/132.1 for indapamide. Rosuvastatin uptake was saturable with KM value of 11.70 and 5.98 mu M for OATP1B1 and OATP2B1. Rosuvastatin could be used as a good probe for studying membrane transporter activity and drug-drug interaction through LC/MS/MS method.
引用
收藏
页码:335 / 341
页数:7
相关论文
共 50 条
  • [1] Identification of natural products as modulators of OATP2B1 using LC-MS/MS to quantify OATP-mediated uptake
    Wen, Fengjiao
    Shi, Meizhi
    Bian, Jialin
    Zhang, Hongjian
    Gui, Chunshan
    PHARMACEUTICAL BIOLOGY, 2016, 54 (02) : 293 - 302
  • [2] Development of a multiplex UPLC-MRM MS method for quantification of human membrane transport proteins OATP1B1, OATP1B3 and OATP2B1 in in vitro systems and tissues
    Ji, Chengjie
    Tschantz, William R.
    Pfeifer, Nathan D.
    Ullah, Mohammed
    Sadagopan, Nalini
    ANALYTICA CHIMICA ACTA, 2012, 717 : 67 - 76
  • [3] Liver uptake of cefditoren is mediated by OATP1B1 and OATP2B1 in humans and Oatp1a1, Oatp1a4, and Oatp1b2 in rats
    Wang, Hepeng
    Sun, Pengyuan
    Wang, Changyuan
    Meng, Qiang
    Liu, Zhihao
    Huo, Xiaokui
    Sun, Huijun
    Ma, Xiaodong
    Peng, Jinyong
    Liu, Kexin
    RSC ADVANCES, 2017, 7 (48): : 30038 - 30048
  • [4] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Nies, Anne T.
    Niemi, Mikko
    Burk, Oliver
    Winter, Stefan
    Zanger, Ulrich M.
    Stieger, Bruno
    Schwab, Matthias
    Schaeffeler, Elke
    GENOME MEDICINE, 2013, 5
  • [5] Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
    Anne T Nies
    Mikko Niemi
    Oliver Burk
    Stefan Winter
    Ulrich M Zanger
    Bruno Stieger
    Matthias Schwab
    Elke Schaeffeler
    Genome Medicine, 5
  • [6] OATP2B1 allelic variants differentially transport rosuvastatin in vitro
    Ho, Richard H.
    Leake, Brenda F.
    Kim, Richard B.
    Wang, Yi
    DRUG METABOLISM REVIEWS, 2006, 38 : 240 - 241
  • [7] Characterization of Ursodeoxycholic and Norursodeoxycholic Acid as Substrates of the Hepatic Uptake Transporters OATP1B1, OATP1B3, OATP2B1 and NTCP
    Koenig, Joerg
    Klatt, Sabine
    Dilger, Karin
    Fromm, Martin F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 111 (02) : 81 - 86
  • [8] ARE OATP1B1, OATP2B1, OATP1B3 AND NTCP TRANSPORTERS EXCLUSIVELY EXPRESSED IN THE PLASMA MEMBRANE OF TRANSPORTER-EXPRESSING CELLS?
    Kumar, Vineet
    Tot Bui Nguyen
    Toth, Beata
    Juhasz, Viktoria
    Unadkat, Jashvant D.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S20 - S21
  • [9] Expression of the organic anion transporters OATP1B1, OATP1B3, and OATP2B1 in human liver is affected by genetic and nongenetic factors
    Nies, A.
    Winter, S.
    Burk, O.
    Klein, K.
    Zanger, U. M.
    Stieger, B.
    Schwab, M.
    Schaeffeler, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 80 - 80
  • [10] Comparison of human and rat drug transporter OATP2B1/Oatp2b1
    Hussner, J.
    Nageleisen, S.
    Seibert, I.
    zu Schwabedissen, H. Meyer
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S61 - S61